(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Riot Blockchain, FAT Brands, and Inovio Pharmaceuticals.

The three biggest losers today are Liberty Media, Merrimack Pharmaceuticals, and Lumen Technologies.

Premarket Winners today

1. Riot Blockchain (RIOT) – Premarket: 3.9%

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain falling 7.2% to $10.77 on Tuesday, following the last session’s downward trend. NASDAQ fell 1.16% to $13,335.78, after two sequential sessions in a row of losses, on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-4.26.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.54%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Riot Blockchain’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 91.8% and 12.5%, respectively.

More news about Riot Blockchain.

2. FAT Brands (FAT) – Premarket: 3.54%

FAT Brands Inc., a multi-brand restaurant company, acquires, develops, markets, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts worldwide. It owns restaurant brands, including Round Table Pizza, Marble Slab Creamery, Great American Cookies, Hot Dog on a Stick, Pretzelmaker, Fazoli's, Fatburger, Johnny Rockets, Elevation Burger, Yalla Mediterranean, Buffalo's Cafe and Buffalo's Express, Hurricane Grill & Wings, Ponderosa Steakhouse / Bonanza Steakhouse, Native Grill & Wings, and Twin Peaks. The company was incorporated in 2017 and is headquartered in Beverly Hills, California. FAT Brands Inc. operates as a subsidiary of Fog Cutter Holdings, LLC.

NASDAQ ended the session with FAT Brands dropping 1.68% to $7.09 on Tuesday while NASDAQ slid 1.16% to $13,335.78.

Earnings Per Share

As for profitability, FAT Brands has a trailing twelve months EPS of $-7.76.

Sales Growth

FAT Brands’s sales growth is 3.9% for the current quarter and 5.1% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 415.51M for the twelve trailing months.

Volatility

FAT Brands’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.33%, a positive 1.12%, and a positive 2.60%.

FAT Brands’s highest amplitude of average volatility was 2.47% (last week), 3.07% (last month), and 2.60% (last quarter).

More news about FAT Brands.

3. Inovio Pharmaceuticals (INO) – Premarket: 3.33%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals falling 2.01% to $0.42 on Tuesday, after four consecutive sessions in a row of losses. NASDAQ slid 1.16% to $13,335.78, after two sequential sessions in a row of losses, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.87.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.

Sales Growth

Inovio Pharmaceuticals’s sales growth is negative 66.8% for the current quarter and negative 58.1% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 42.3%, now sitting on 10.18M for the twelve trailing months.

More news about Inovio Pharmaceuticals.

4. Vanguard Total (VXUS) – Premarket: 2.45%

NASDAQ ended the session with Vanguard Total rising 0.25% to $55.19 on Tuesday, following the last session’s upward trend. NASDAQ slid 1.16% to $13,335.78, after two consecutive sessions in a row of losses, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Vanguard Total has a trailing twelve months EPS of $2.99.

PE Ratio

Vanguard Total has a trailing twelve months price to earnings ratio of 12.07. Meaning, the purchaser of the share is investing $12.07 for every dollar of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Vanguard Total’s stock is considered to be overbought (>=80).

Volatility

Vanguard Total’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.45%, a negative 0.01%, and a positive 0.63%.

Vanguard Total’s highest amplitude of average volatility was 0.62% (last week), 0.83% (last month), and 0.63% (last quarter).

Volume

Today’s last reported volume for Vanguard Total is 2361710 which is 2.52% above its average volume of 2303590.

More news about Vanguard Total.

5. Bionano Genomics (BNGO) – Premarket: 2.29%

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

NASDAQ ended the session with Bionano Genomics sliding 7.33% to $0.57 on Tuesday, after five consecutive sessions in a row of losses. NASDAQ dropped 1.16% to $13,335.78, after two sequential sessions in a row of losses, on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, Bionano Genomics has a trailing twelve months EPS of $-0.44.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.51%.

Volatility

Bionano Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.67%, a negative 0.65%, and a positive 4.49%.

Bionano Genomics’s highest amplitude of average volatility was 4.67% (last week), 3.51% (last month), and 4.49% (last quarter).

Sales Growth

Bionano Genomics’s sales growth is 24.3% for the ongoing quarter and 41.4% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Bionano Genomics’s stock is considered to be overbought (>=80).

More news about Bionano Genomics.

6. Logitech (LOGI) – Premarket: 1.79%

Logitech International S.A., through its subsidiaries, designs, manufactures, and markets products that connect people to working, creating, gaming, and streaming worldwide. The company offers pointing devices, such as wireless mouse; corded and cordless keyboards, living room keyboards, and keyboard-and-mouse combinations; PC webcams; and keyboards for tablets and smartphones, as well as other accessories for mobile devices. It also provides keyboards, mice, headsets, and simulation products, such as gamepads, steering wheels, simulation controllers, console gaming headsets, and streamlabs services; video conferencing products, such as ConferenceCams, which combine enterprise-quality audio and high-definition video to bring video conferencing to businesses of any size; webcams and headsets that turn desktop into collaboration space; and controller for video conferencing room solutions. In addition, the company offers portable wireless Bluetooth and Wi-Fi connected speakers, mobile speakers, PC speakers, PC headsets, microphones, in-ear headphones, and wireless audio wearables. Its channel network includes consumer electronics distributors, retailers, e-tailers, computer and telecommunications stores, value-added resellers, and online merchants. The company sells its products under the Logitech, Logitech G, ASTRO Gaming, Streamlabs, Blue Microphones, and Ultimate Ears brands. Logitech International S.A. was incorporated in 1981 and is headquartered in Lausanne, Switzerland.

NASDAQ ended the session with Logitech dropping 0.97% to $55.26 on Tuesday, following the last session’s downward trend. NASDAQ dropped 1.16% to $13,335.78, after two consecutive sessions in a row of losses, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Logitech has a trailing twelve months EPS of $2.23.

PE Ratio

Logitech has a trailing twelve months price to earnings ratio of 24.78. Meaning, the purchaser of the share is investing $24.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.66%.

Yearly Top and Bottom Value

Logitech’s stock is valued at $55.26 at 08:34 EST, way below its 52-week high of $68.17 and way higher than its 52-week low of $41.81.

More news about Logitech.

7. Kinross Gold (KGC) – Premarket: 1.08%

Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania. It is also involved in the extraction and processing of gold-containing ores; reclamation of gold mining properties; and production and sale of silver. Kinross Gold Corporation was founded in 1993 and is headquartered in Toronto, Canada.

NYSE ended the session with Kinross Gold rising 0.87% to $4.65 on Tuesday, following the last session’s upward trend. NYSE jumped 0.32% to $15,518.74, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Kinross Gold has a trailing twelve months EPS of $0.03.

PE Ratio

Kinross Gold has a trailing twelve months price to earnings ratio of 155. Meaning, the purchaser of the share is investing $155 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.64%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kinross Gold’s EBITDA is 2.24.

More news about Kinross Gold.

8. Groupon (GRPN) – Premarket: 0.96%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon dropping 4.76% to $5.23 on Tuesday, following the last session’s downward trend. NASDAQ dropped 1.16% to $13,335.78, after two sequential sessions in a row of losses, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-8.74.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -285.15%.

Volatility

Groupon’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.50%, a negative 0.08%, and a positive 5.79%.

Groupon’s highest amplitude of average volatility was 7.98% (last week), 6.32% (last month), and 5.79% (last quarter).

More news about Groupon.

9. KeyCorp (KEY) – Premarket: 0.64%

KeyCorp operates as the holding company for KeyBank National Association that provides various retail and commercial banking products and services in the United States. It operates in two segments, Consumer Bank and Commercial Bank. The company offers various deposits, investment products and services; and personal finance and financial wellness, student loan refinancing, mortgage and home equity, lending, credit card, treasury, business advisory, wealth management, asset management, investment, cash management, portfolio management, and trust and related services to individuals and small and medium-sized businesses. It also provides a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans comprising consumer, energy, healthcare, industrial, public sector, real estate, and technology loans for middle market clients. In addition, the company offers community development financing, securities underwriting, brokerage, and investment banking services. The company was founded in 1849 and is headquartered in Cleveland, Ohio.

NYSE ended the session with KeyCorp falling 0.05% to $9.35 on Tuesday, after five consecutive sessions in a row of losses. NYSE rose 0.32% to $15,518.74, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, KeyCorp has a trailing twelve months EPS of $1.77.

PE Ratio

KeyCorp has a trailing twelve months price to earnings ratio of 5.28. Meaning, the purchaser of the share is investing $5.28 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.98%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, KeyCorp’s stock is considered to be overbought (>=80).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 25, 2023, the estimated forward annual dividend rate is 0.82 and the estimated forward annual dividend yield is 8.77%.

Previous days news about KeyCorp

• Keycorp (key) flat as market sinks: what you should know. According to Zacks on Monday, 26 June, "Any recent changes to analyst estimates for KeyCorp should also be noted by investors. ", "On that day, KeyCorp is projected to report earnings of $0.35 per share, which would represent a year-over-year decline of 35.19%. "

More news about KeyCorp.

10. Datadog (DDOG) – Premarket: 0.62%

Datadog, Inc. operates an observability and security platform for cloud applications in North America and internationally. The company's products include infrastructure and application performance monitoring, log management, digital experience monitoring, continuous profiler, database monitoring, network monitoring, incident management, observability pipelines, cloud cost management, universal service monitoring, cloud security management, application security management. cloud SIEM, sensitive data scanner, and CI Visibility. The company was incorporated in 2010 and is headquartered in New York, New York.

NASDAQ ended the session with Datadog falling 0.35% to $93.34 on Tuesday while NASDAQ slid 1.16% to $13,335.78.

Earnings Per Share

As for profitability, Datadog has a trailing twelve months EPS of $-0.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.39%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Datadog’s EBITDA is 16.15.

Yearly Top and Bottom Value

Datadog’s stock is valued at $93.34 at 08:34 EST, way under its 52-week high of $120.75 and way higher than its 52-week low of $61.34.

More news about Datadog.

Premarket Losers Today

1. Liberty Media (LSXMB) – Premarket: -7.2%

The Liberty SiriusXM Group, through its subsidiaries, engages in the entertainment business in the United States and Canada. It features music, sports, entertainment, comedy, talk, news, traffic, weather channels, podcast, and infotainment services through proprietary satellite radio systems, as well as streamed through applications for mobile and home devices, and other consumer electronic equipment. It also offers connected vehicle services; a suite of data services that include graphical weather, fuel prices, sports schedules and scores, and movie listings; and traffic information services, which provide information as to road closings, traffic flow and incident data to consumers with compatible in-vehicle navigation systems, and real-time weather services in vehicles, boats, and planes. In addition, the company operates a music, comedy, and podcast streaming platform. Further, it offers ad-supported radio services; Pandora Plus, a radio subscription service; and Pandora Premium, an on-demand subscription service. Additionally, the company distributes satellite radios through automakers and retailers, as well as through its website. As of December 31, 2021, it served approximately 34.0 million subscribers through Sirius XM and approximately 6.4 million subscribers through Pandora. The Liberty SiriusXM Group is based in Englewood, Colorado. The Liberty SiriusXM Group operates as a subsidiary of Liberty Media Corporation.

NASDAQ ended the session with Liberty Media rising 0.86% to $27.99 on Tuesday, after five successive sessions in a row of losses. NASDAQ slid 1.16% to $13,335.78, after two consecutive sessions in a row of losses, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Liberty Media has a trailing twelve months EPS of $3.22.

PE Ratio

Liberty Media has a trailing twelve months price to earnings ratio of 8.69. Meaning, the purchaser of the share is investing $8.69 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.79%.

More news about Liberty Media.

2. Merrimack Pharmaceuticals (MACK) – Premarket: -2.79%

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Merrimack Pharmaceuticals falling 1.38% to $12.19 on Tuesday while NASDAQ fell 1.16% to $13,335.78.

Earnings Per Share

As for profitability, Merrimack Pharmaceuticals has a trailing twelve months EPS of $-0.12.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.12%.

More news about Merrimack Pharmaceuticals.

3. Lumen Technologies (LUMN) – Premarket: -2.51%

Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as edge cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based ethernet, legacy data hosting services, and conferencing services. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. The company was incorporated in 1968 and is headquartered in Monroe, Louisiana.

NYSE ended the session with Lumen Technologies jumping 9.07% to $1.99 on Tuesday, after two consecutive sessions in a row of gains. NYSE jumped 0.32% to $15,518.74, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Lumen Technologies has a trailing twelve months EPS of $-1.58.

Volume

Today’s last reported volume for Lumen Technologies is 12792400 which is 45.89% below its average volume of 23645100.

Volatility

Lumen Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.09%, a negative 0.47%, and a positive 3.89%.

Lumen Technologies’s highest amplitude of average volatility was 5.09% (last week), 4.36% (last month), and 3.89% (last quarter).

More news about Lumen Technologies.

4. NeuroMetrix (NURO) – Premarket: -1.54%

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with NeuroMetrix falling 3.91% to $0.98 on Tuesday, following the last session’s downward trend. NASDAQ dropped 1.16% to $13,335.78, after two successive sessions in a row of losses, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.76%.

Yearly Top and Bottom Value

NeuroMetrix’s stock is valued at $0.98 at 08:34 EST, way below its 52-week high of $4.73 and above its 52-week low of $0.93.

Revenue Growth

Year-on-year quarterly revenue growth declined by 25.1%, now sitting on 7.68M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NeuroMetrix’s stock is considered to be overbought (>=80).

More news about NeuroMetrix.

5. Aurora Cannabis (ACB) – Premarket: -1.35%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.

NYSE ended the session with Aurora Cannabis sliding 1.22% to $0.54 on Tuesday, after four consecutive sessions in a row of losses. NYSE jumped 0.32% to $15,518.74, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-5.87.

More news about Aurora Cannabis.

6. Ventas (VTR) – Premarket: -1.35%

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

NYSE ended the session with Ventas rising 3.14% to $45.87 on Tuesday while NYSE rose 0.32% to $15,518.74.

Earnings Per Share

As for profitability, Ventas has a trailing twelve months EPS of $-0.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.58%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.6%, now sitting on 4.17B for the twelve trailing months.

Yearly Top and Bottom Value

Ventas’s stock is valued at $45.87 at 08:34 EST, way under its 52-week high of $54.11 and way above its 52-week low of $35.33.

Moving Average

Ventas’s worth is higher than its 50-day moving average of $45.47 and higher than its 200-day moving average of $45.21.

Sales Growth

Ventas’s sales growth is 6.8% for the present quarter and 8.7% for the next.

More news about Ventas.

7. Western Digital (WDC) – Premarket: -0.85%

Western Digital Corporation develops, manufactures, and sells data storage devices and solutions in the United States, China, Hong Kong, Europe, the Middle East, Africa, rest of Asia, and internationally. It offers client devices, including hard disk drives (HDDs) and solid state drives (SSDs) for computing devices, such as desktop and notebook personal computers (PCs), smart video systems, gaming consoles, and set top boxes; flash-based embedded storage products for mobile phones, tablets, notebook PCs, and other portable and wearable devices, as well as automotive, Internet of Things, industrial, and connected home applications; and flash-based memory wafers. The company also provides enterprise helium hard drives; enterprise SSDs consisting of flash-based SSDs and software solutions for use in enterprise servers, on-line transactions, data analysis, and other enterprise applications; drives are used for data storage systems and tiered storage models; and data storage platforms. In addition, it offers client solutions, such as external HDD storage products in mobile and desktop form; client portable SSDs; removable cards that are used in consumer devices comprising mobile phones, tablets, imaging systems, and cameras and smart video systems; universal serial bus flash drives for use in the computing and consumer markets; and wireless drive products used in-field back up of created content, as well as wireless streaming of high-definition movies, photos, music, and documents to tablets, smartphones, and PCs. The company sells its products under the Western Digital, SanDisk, and WD brands to original equipment manufacturers, distributors, dealers, resellers, and retailers. Western Digital Corporation was founded in 1970 and is headquartered in San Jose, California.

NASDAQ ended the session with Western Digital falling 0.79% to $37.56 on Tuesday, after five successive sessions in a row of losses. NASDAQ slid 1.16% to $13,335.78, after two sequential sessions in a row of losses, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Western Digital has a trailing twelve months EPS of $-2.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.64%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Western Digital’s EBITDA is 1.26.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Western Digital’s stock is considered to be overbought (>=80).

More news about Western Digital.

8. Halliburton Company (HAL) – Premarket: -0.82%

Halliburton Company provides products and services to the energy industry worldwide. It operates in two segments, Completion and Production, and Drilling and Evaluation. The Completion and Production segment offers production enhancement services that include stimulation and sand control services; cementing services, such as well bonding and casing, and casing equipment; completion tools that offer downhole solutions and services, including well completion products and services, intelligent well completions, and service tools, as well as liner hanger, sand control, and multilateral systems; production solutions comprising coiled tubing, hydraulic workover units, downhole tools, and pumping and nitrogen services; and pipeline and process services, such as pre-commissioning, commissioning, maintenance, and decommissioning. This segment also provides electrical submersible pumps, as well as artificial lift services. The Drilling and Evaluation segment offers drilling fluid systems, performance additives, completion fluids, solids control, specialized testing equipment, and waste management services; oilfield completion, production, and downstream water and process treatment chemicals and services; drilling systems and services; wireline and perforating services consists of open-hole logging, and cased-hole and slickline; and drill bits and services comprising roller cone rock bits, fixed cutter bits, hole enlargement, and related downhole tools and services, as well as coring equipment and services. This segment also provides cloud based digital services and artificial intelligence solutions on an open architecture for subsurface insights, integrated well construction, and reservoir and production management; testing and subsea services, such as acquisition and analysis of reservoir information and optimization solutions; and project management and integrated asset management services. Halliburton Company was founded in 1919 and is based in Houston, Texas.

NYSE ended the session with Halliburton Company jumping 2.51% to $31.67 on Tuesday while NYSE jumped 0.32% to $15,518.74.

Earnings Per Share

As for profitability, Halliburton Company has a trailing twelve months EPS of $2.16.

PE Ratio

Halliburton Company has a trailing twelve months price to earnings ratio of 14.66. Meaning, the purchaser of the share is investing $14.66 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.66%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 32.5%, now sitting on 21.69B for the twelve trailing months.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 5, 2023, the estimated forward annual dividend rate is 0.64 and the estimated forward annual dividend yield is 2.07%.

More news about Halliburton Company.

9. iShares (PFF) – Premarket: 0%

NASDAQ ended the session with iShares jumping 0.46% to $30.59 on Tuesday, following the last session’s upward trend. NASDAQ fell 1.16% to $13,335.78, after two successive sessions in a row of losses, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, iShares has a trailing twelve months EPS of $6.8.

PE Ratio

iShares has a trailing twelve months price to earnings ratio of 3.79. Meaning, the purchaser of the share is investing $3.79 for every dollar of annual earnings.

Volume

Today’s last reported volume for iShares is 2405310 which is 31.8% below its average volume of 3527270.

More news about iShares.

10. Telefonica (TEF) – Premarket: 0%

Telefónica, S.A., together with its subsidiaries, provides telecommunications services in Europe and Latin America. The company's mobile and related services and products comprise mobile voice, value added, mobile data and Internet, wholesale, corporate, roaming, fixed wireless, and trunking and paging services. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone services; local, domestic, and international long-distance and fixed-to-mobile communications; corporate communications; supplementary value-added services; video telephony; intelligent network; and telephony information services, as well as leases and sells handset equipment. The company also provides Internet and broadband multimedia services comprising Internet service provider, portal and network, retail and wholesale broadband access, narrowband switched access, high-speed Internet through fibre to the home, and voice over Internet protocol services. In addition, it offers leased line, virtual private network, fibre optics, web hosting and application, managed hosting, content delivery, outsourcing and consultancy, desktop, and system integration and professional services. Further, the company offers wholesale services for telecommunication operators, including domestic interconnection and international wholesale services; leased lines for other operators; and local loop leasing services, as well as bit stream services, wholesale line rental accesses, and leased ducts for other operators' fiber deployment. Additionally, it provides video/TV services; smart connectivity and services, and consumer IoT products; financial and other payment, security, cloud, advertising, big data, and digital experience services; virtual assistants; and Movistar Home devices. The company was incorporated in 1924 and is headquartered in Madrid, Spain.

NYSE ended the session with Telefonica sliding 0.89% to $3.89 on Tuesday, after two successive sessions in a row of losses. NYSE jumped 0.32% to $15,518.74, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Telefonica has a trailing twelve months EPS of $0.26.

PE Ratio

Telefonica has a trailing twelve months price to earnings ratio of 14.94. Meaning, the purchaser of the share is investing $14.94 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.13%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Telefonica’s EBITDA is 0.54.

More news about Telefonica.

Stay up to date with our premarket winners and losers daily report